Press release: the children T1D trial has demonstrated the clinical safety and efficacy of Stem Cell Educator therapy for the treatment of children with type 1 diabetes.

Press release from the Second Xiangya Hospital of Central South University: the children T1D trial (NCT01996228) has demonstrated the clinical safety and efficacy of Stem Cell Educator therapy for the treatment of children with type 1 diabetes (n = 40). This project has been supported by the Ministry of Science and Technology of the P.R. China.